🔎 Trials Near Me

Dachaigh › Liomfoma Neo-Hodgkin › Utah › Salt Lake City

Sgrùdaidhean clionaigeach Liomfoma Neo-Hodgkin ann an Salt Lake City, UT

Tha 13 sgrùdaidhean airson Liomfoma Neo-Hodgkin a’ lorg phàirtichean aig làraichean ann agus timcheall air Salt Lake City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

A’ fastadhÌre 1/2
  • Intermountain Health, Canyons Region, LDS Hospital, Salt Lake City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06343311

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

A’ fastadhÌre 2
  • Intermountain Healthcare, Salt Lake City
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT02693535

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

A’ fastadhÌre 1
  • Intermountain Healthcare, Salt Lake City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07101328

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

A’ fastadhÌre 1/2
  • Huntsman Cancer Institute, Salt Lake City
  • Intermountain Healthcare, Salt Lake City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

A’ fastadhÌre 3
  • Intermountain Healthcare, Salt Lake City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT07188558

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

A’ fastadhÌre 1
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Iuch 2026 · NCT05077527

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • University of Utah, Salt Lake City
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

A’ fastadhÌre 1
  • University of Utah, Salt Lake City
Aoisean 13 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT04771572

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

A’ fastadhÌre 1/2
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT03328078

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

A’ fastadhSgrùdadh amharc
  • Huntsman Cancer Institute at the University of Utah, Salt Lake City
Gach aois · Gach gnè · Air ùrachadh 22 Faoi 2026 · NCT06357754

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

A’ fastadhÌre 1/2
  • University of Utah, Salt Lake City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Samh 2025 · NCT05643742

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, Salt Lake City
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

A’ fastadhSgrùdadh amharc
  • University of Utah Hospital, Salt Lake City
Gach aois · Gach gnè · Air ùrachadh 22 Dàmh 2025 · NCT02848274

Sgrùdaidhean Liomfoma Neo-Hodgkin ann am bailtean eile

Sgrùdaidhean eile ann an Salt Lake City

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.